Latest News
Beyond Tolvaptan: The Next Generation of ADPKD Therapies
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder and the leading monogenic cause of kidney failure worldwide, affecting an estimated 12.5 million people globally. For nearly a decade, tolvaptan — a vasopressin V2...
Latest News
Webinar: Decoding Neurodegeneration via iPSC-Derived Human Brain Models
The human brain presents an intricate evolutionary paradox. While its sophisticated neural networks govern complex cognition, its architecture is uniquely susceptible to progressive degradation. For decades, the biomedical community has grappled with an uncomfortable...
Why the Immune System Is Becoming the New Battlefield in Cancer Care
The Old Paradigm For more than a century, cancer treatment has been defined by a straightforward objective: find the tumor and destroy it. Surgery removes it, radiation damages it. Chemotherapy attacks rapidly dividing cells. These approaches have saved countless...
CE Marking Is Not Enough: Three Layers for Connected Medical Devices
If your device connects to a network and runs AI, CE marking under MDR or IVDR is only the first layer for connected medical devices. Two further EU frameworks, the AI Act and the Cyber Resilience Act, can also apply, each with obligations that go beyond what MDR...
When Months Become Days: AI’s Edge in Patient Engagement
Every therapy that reaches a patient first has to clear a quieter hurdle that rarely makes headlines: finding enough of the right people to test it. That hurdle is where most clinical programs stumble. Roughly 80% of clinical trials fail to meet their enrollment...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Phacilitate Unites CGT Community for New Era Defined by Collaboration
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
Natural Product Drug Discovery Returns With New Anti Cancer Insights
Scientists have uncovered how plants produce mitraphylline, a rare natural compound with demonstrated anti cancer properties, shedding new light on the biological machinery behind one of nature’s most complex chemical products. By identifying the key enzymes involved...
Biotech’s Funding Winter is Over, but M&A Will Remain Selective
Biotech is showing early signs of life after a prolonged funding winter, but for many early-stage companies, conditions remain unforgiving. Years of low valuations, high borrowing costs and regulatory uncertainty have reshaped investor behaviour, with capital scarce...
Thousands Benefit From New Treatment for Advanced Prostate Cancer
NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment. Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23...
A Career in Life Sciences: Pathways, Possibilities and Support
The life sciences sector sits at the intersection of discovery, technology and human impact. From developing new medicines and diagnostics to advancing environmental sustainability and digital health, careers in life sciences offer the chance to work on problems that...
MRI Study Links Inflammation in Brain Reward Centre to Depression Severity
New research suggests that inflammatory and microstructural changes in a key brain reward region may differ between chronic depression and acute depressive symptoms, offering fresh insight into the biological mechanisms underlying the condition. In a large scale...
‘The World Has Not Yet Learned From the COVID Crisis’ Experts Warn
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Recovery as Signal Engineering: How Stress Upgrades Human Physiology
For decades, recovery has been framed as the absence of stress. Rest, relaxation, sleep, and passive modalities have been treated as the antidote to physiological load. While these elements matter, they represent only a fraction of how biological systems actually...
Novo Nordisk and Aspect Biosystems Expand Diabetes Collaboration
Novo Nordisk and Aspect Biosystems expand collaboration to accelerate curative diabetes therapies The landscape of regenerative medicine has shifted significantly following the announcement that Novo Nordisk and Aspect Biosystems are entering a comprehensive new phase...
Why Every Business Leader Should be Assessing Their Brain in 2026
As a business leader, we reflect on so much of our performance but not the thing that's driving it: our brains. Yet it's our brain anatomy which is truly individualised and unique to each business owner. Without it, our business cannot run. As a cognitive health...
GSK Makes $2.2 Billion Bid for RAPT Therapeutics
GSK has agreed to acquire US biotech company RAPT Therapeutics in a deal valued at approximately 2.2 billion US dollars, strengthening its position in immunology and signalling a major push into the emerging food allergy treatment market. The acquisition centres on...
What is the Metabolic Reset Diet – The Science
The science, the promise, and the pitfalls The idea of a “metabolic reset” has gained traction across wellness media, social platforms, and weight management programmes. The premise is appealing: that metabolism can be “retrained” or “rebooted” through short-term...
Phacilitate Unites CGT Community for New Era Defined by Collaboration
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
Natural Product Drug Discovery Returns With New Anti Cancer Insights
Scientists have uncovered how plants produce mitraphylline, a rare natural compound with demonstrated anti cancer properties, shedding new light on the biological machinery behind one of nature’s most complex chemical products. By identifying the key enzymes involved...
Biotech’s Funding Winter is Over, but M&A Will Remain Selective
Biotech is showing early signs of life after a prolonged funding winter, but for many early-stage companies, conditions remain unforgiving. Years of low valuations, high borrowing costs and regulatory uncertainty have reshaped investor behaviour, with capital scarce...
Thousands Benefit From New Treatment for Advanced Prostate Cancer
NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment. Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23...
A Career in Life Sciences: Pathways, Possibilities and Support
The life sciences sector sits at the intersection of discovery, technology and human impact. From developing new medicines and diagnostics to advancing environmental sustainability and digital health, careers in life sciences offer the chance to work on problems that...
MRI Study Links Inflammation in Brain Reward Centre to Depression Severity
New research suggests that inflammatory and microstructural changes in a key brain reward region may differ between chronic depression and acute depressive symptoms, offering fresh insight into the biological mechanisms underlying the condition. In a large scale...
‘The World Has Not Yet Learned From the COVID Crisis’ Experts Warn
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Recovery as Signal Engineering: How Stress Upgrades Human Physiology
For decades, recovery has been framed as the absence of stress. Rest, relaxation, sleep, and passive modalities have been treated as the antidote to physiological load. While these elements matter, they represent only a fraction of how biological systems actually...
Novo Nordisk and Aspect Biosystems Expand Diabetes Collaboration
Novo Nordisk and Aspect Biosystems expand collaboration to accelerate curative diabetes therapies The landscape of regenerative medicine has shifted significantly following the announcement that Novo Nordisk and Aspect Biosystems are entering a comprehensive new phase...
Why Every Business Leader Should be Assessing Their Brain in 2026
As a business leader, we reflect on so much of our performance but not the thing that's driving it: our brains. Yet it's our brain anatomy which is truly individualised and unique to each business owner. Without it, our business cannot run. As a cognitive health...
GSK Makes $2.2 Billion Bid for RAPT Therapeutics
GSK has agreed to acquire US biotech company RAPT Therapeutics in a deal valued at approximately 2.2 billion US dollars, strengthening its position in immunology and signalling a major push into the emerging food allergy treatment market. The acquisition centres on...
What is the Metabolic Reset Diet – The Science
The science, the promise, and the pitfalls The idea of a “metabolic reset” has gained traction across wellness media, social platforms, and weight management programmes. The premise is appealing: that metabolism can be “retrained” or “rebooted” through short-term...
Featured Articles
Further News
Obesity Redefinition Studies Challenge Longstanding Clinical Standards
For decades, obesity has been defined and diagnosed primarily using body mass index (BMI), a simple ratio of weight to height. While BMI has been widely adopted for its convenience and scalability, a growing body of research now suggests that it may be an incomplete...
Functional Gut Clinic Launches GI Clinical Trials Division
The Functional Gut Clinic (FGC), the UK’s leading provider of specialist gastrointestinal (GI) diagnostics, today announced the launch of its dedicated GI Clinical Trials establishing the organisation as the country’s first boutique, end‑to‑end clinical research...
Japan’s iPSC Breakthrough: A New Hope for Spinal Cord Injury Repair
Spinal cord injuries remain one of the most challenging conditions in modern medicine. Damage to the spinal cord often leads to permanent paralysis, loss of sensation, and a dramatic decline in quality of life. For decades, treatment options have been limited to...
Life Extending Prostate Cancer Drug to be Offered to Thousands in England
Thousands of men in England with advanced prostate cancer are set to gain access to a new life extending treatment following a decision by the National Institute for Health and Care Excellence. The move marks a significant development in the management of one of the...
Ergonomic Design Considerations in Health Tech
Why comfort and fit are essential design considerations in medical devices In many industries, product design rarely accounts for the variability of user profiles, with a focus on the ‘average’ person. Headphones or even glasses too often do not account for head size...
EQT Targets Oxford Biomedica in Major Biotech Takeover Bid
Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...
Thermo Fisher Reshoring Surge: Strategic Shift to U.S. Manufacturing
In a move that signals a significant shift in the global pharmaceutical supply chain landscape, Thermo Fisher Scientific (NYSE: TMO) has announced a substantial influx of new contracts within its pharmaceutical services business. The common thread among these new...
UK Boosts Clinical Trials With Faster, Agile Regulation
Press Release: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more...
Five Ways AI Will Reshape Life Sciences in 2026
Why People, Process, and Purpose Matter Most Following a period of experimentation, life sciences is entering a pivotal new phase in AI adoption. The industry is shifting away from hype-driven pilots and toward proven, value-led applications that improve how therapies...
Communication Breakdown: Why Soft Skills Are More Important Than Ever in Life Sciences
We all know or work with people who can be difficult to deal with and even talk to, and we all know or work with other people who are a joy to be around and who make the working day a little brighter. Some of those difficult people will be highly competent in their...
Why Hormone Tracking will be a Key Health Trend for 2026
Hormone health expert and bestselling author Dr Louise Newson explains why we'll all be tracking our hormones in 2026. The use of period tracking apps and menopause symptom tracker apps are at an all-time high. And it’s no wonder. These apps can be incredibly useful...
The Research Partnership That Looked Perfect – Until it Wasn’t
The dream is always the same: strike out on your own and build something that’s truly yours. Perhaps you’re spinning out from a university, commercialising years of research with a fellow academic who shares your vision. Or maybe you’re breaking away from the big...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.